You can buy or sell Acer and other stocks, options, and ETFs commission-free!
Acer Therapeutics Inc. Common Stock (DE), also called Acer, is a pharmaceutical company. The firm engages in the acquisition, development and commercialization of therapies for medical needs. Its product pipeline includes Edsivo and ACER-001. The Edsivo is a type of celiprolol for Vascular Ehlers-Danlos syndrome. The ACER-001 is for the treatment of urea cycle disorders and Maple Syrup Urine diseases. The company was founded by Christopher Schelling on September 19, 2017 and is headquartered in Newton, MA. The listed name for ACER is Acer Therapeutics Inc. Common Stock (DE).
52 Week High
52 Week Low
— per share
Expected Mar 18, After Hours